Division of Gastroenterological Surgery, Saitama Medical University International Medical Center, 1397 Yamane, Hidaka-shi, Saitama, 350-1298, Japan.
Division of Esophageal Surgery, Shizuoka Cancer Center Hospital, Nagaizumi, Japan.
Gen Thorac Cardiovasc Surg. 2022 Feb;70(2):170-177. doi: 10.1007/s11748-021-01717-y. Epub 2021 Oct 1.
Data are sparse regarding the multidisciplinary perioperative enhanced recovery after surgery protocol (E-P) for thoracic esophageal cancer surgery that was newly used at another institution. Therefore, this study aimed to retrospectively evaluate the effectiveness and safety of the protocol.
We enrolled 101 patients who underwent transthoracic esophagectomy for E-P at the Shizuoka Cancer Center Hospital (SCC). The outcomes obtained at the SCC were compared with the outcomes of 140 patients treated with E-P at the Saitama Medical University International Medical Center (SMU). At the SMU, we compared the results before and after the introduction of E-P.
The rates of morbidity, pulmonary complications, and postoperative pneumonia were 44%, 31%, and 6.9% at the SCC and 44%, 27%, and 6.5% at the SMU (P = 0.91, 0.55, and 0.88, respectively). The mean time to walk was 1.1 and 1.5 days at the SCC and SMU, respectively (P < 0.001). The median length of hospital stay was longer at the SMU than at the SCC (24.0 versus 20.8 days; P = 0.004). In the comparative study before and after the introduction of E-P, the rate of postoperative pneumonia was 16% in the conventional management group and 6.5% in the E-P group (P = 0.02).
Postoperative pneumonia was reduced before and after introduction of E-P. As similar short-term postoperative outcomes were promising (except for the time to walk and postoperative hospital stay), the same E-P that was safely performed at the SMU can be implemented as a standard practice.
其他机构新采用的胸段食管癌手术多学科围手术期加速康复外科(E-P)方案的数据较为匮乏。因此,本研究旨在回顾性评估该方案的有效性和安全性。
我们纳入了 101 例在静冈癌症中心医院(SCC)接受 E-P 经胸食管切除术的患者。将 SCC 的结果与在埼玉医科大学国际医疗中心(SMU)接受 E-P 治疗的 140 例患者的结果进行比较。在 SMU,我们比较了引入 E-P 前后的结果。
SCC 的发病率、肺部并发症和术后肺炎发生率分别为 44%、31%和 6.9%,SMU 为 44%、27%和 6.5%(P=0.91、0.55 和 0.88)。SCC 和 SMU 患者术后下床活动的平均时间分别为 1.1 和 1.5 天(P<0.001)。SMU 的中位住院时间长于 SCC(24.0 天比 20.8 天;P=0.004)。在引入 E-P 前后的比较研究中,常规治疗组和 E-P 组的术后肺炎发生率分别为 16%和 6.5%(P=0.02)。
引入 E-P 前后术后肺炎发生率降低。由于相似的短期术后结局令人满意(除了术后下床活动时间和术后住院时间),在 SMU 安全实施的相同 E-P 可以作为标准实践。